ストックスクリーナーアプリを入手
52.62
3.09%
-1.68
前日終値:
$54.30
開ける：
$53.85
24時間の取引高:
852.44K
Relative Volume:
1.68
時価総額：
$3.34B
収益：
-
当期純損益:
$-145.21M
株価収益率:
-22.88
EPS:
-2.3
ネットキャッシュフロー:
$-140.12M
1週間 パフォーマンス:
-11.47%
1か月 パフォーマンス:
-4.05%
6か月 パフォーマンス:
+33.86%
1年 パフォーマンス:
+3.10%
1日の値動き範囲:
$52.45
$54.97
1週間の範囲:
$52.45
$61.17
52週間の値動き範囲:
$31.42
$61.87
Moonlake Immunotherapeutics Stock (MLTX) Company Profile
MLTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MLTX
Moonlake Immunotherapeutics
|
52.62 | 3.44B | 0 | -145.21M | -140.12M | -2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Moonlake Immunotherapeutics Stock (MLTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-28 | 開始されました | Rothschild & Co Redburn | Neutral |
| 2025-05-19 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-01-17 | アップグレード | Goldman | Neutral → Buy |
| 2024-11-05 | 再開されました | Wedbush | Outperform |
| 2024-08-26 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | 開始されました | Oppenheimer | Outperform |
| 2024-04-02 | 開始されました | Goldman | Neutral |
| 2024-02-15 | 開始されました | Wolfe Research | Outperform |
| 2023-12-08 | 開始されました | Citigroup | Buy |
| 2023-11-02 | 開始されました | Stifel | Buy |
| 2023-09-14 | ダウングレード | Bryan Garnier | Buy → Neutral |
| 2023-08-31 | 開始されました | Needham | Buy |
| 2023-06-15 | 開始されました | Barclays | Equal Weight |
| 2023-05-01 | 開始されました | Guggenheim | Buy |
| 2023-03-22 | 開始されました | Wedbush | Outperform |
| 2023-03-09 | 開始されました | BTIG Research | Buy |
| 2023-02-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-02-02 | 開始されました | Bryan Garnier | Buy |
| 2022-11-11 | 開始されました | Jefferies | Buy |
| 2022-08-25 | 開始されました | SVB Leerink | Outperform |
| 2022-07-21 | 開始されました | H.C. Wainwright | Buy |
| 2022-07-07 | 開始されました | Cowen | Outperform |
すべてを表示
Moonlake Immunotherapeutics (MLTX) 最新ニュース
MoonLake Immunotherapeutics (MLTX): Is the Current Valuation Supported by Growth Potential? - simplywall.st
MoonLake Immunotherapeutics (NASDAQ:MLTX) Shares Down 6.9%What's Next? - MarketBeat
MoonLake Immunotherapeutics (MLTX) Q2 Net Loss Widens to US$55 Million - uk.finance.yahoo.com
MoonLake Immunotherapeutics $MLTX Shares Sold by Fred Alger Management LLC - MarketBeat
Psoriasis Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | AnaptysBio, Nimbus Lakshmi/Takeda, MoonLake Immunotherapeutics, Can-Fite Biopharma - Barchart.com
Zimmer Partners LP Makes New Investment in MoonLake Immunotherapeutics $MLTX - MarketBeat
Biotech UCB’s Big Rally Has a Lot Riding on Rival’s Trial Result - SWI swissinfo.ch
Alliancebernstein L.P. Sells 56,514 Shares of MoonLake Immunotherapeutics $MLTX - MarketBeat
Octagon Capital Advisors LP Buys Shares of 296,000 MoonLake Immunotherapeutics $MLTX - MarketBeat
Granahan Investment Management LLC Has $5.56 Million Stock Position in MoonLake Immunotherapeutics $MLTX - MarketBeat
Cubist Systematic Strategies LLC Takes Position in MoonLake Immunotherapeutics $MLTX - MarketBeat
Leerink Partners Reiterated a Buy on MoonLake Immunotherapeutics (MLTX) - Yahoo Finance
FY2025 EPS Estimates for MLTX Decreased by Cantor Fitzgerald - MarketBeat
ADAR1 Capital Management LLC Sells 12,000 Shares of MoonLake Immunotherapeutics $MLTX - MarketBeat
MoonLake Immunotherapeutics (NASDAQ:MLTX) Hits New 1-Year HighStill a Buy? - MarketBeat
Russell Investments Group Ltd. Sells 50,430 Shares of MoonLake Immunotherapeutics $MLTX - MarketBeat
Vestal Point Capital LP Acquires Shares of 200,000 MoonLake Immunotherapeutics $MLTX - MarketBeat
What’s the analyst consensus on MoonLake ImmunotherapeuticsTrade Analysis Summary & Fast Entry High Yield Tips - خودرو بانک
Forecasting MoonLake Immunotherapeutics price range with options dataRecession Risk & Daily Growth Stock Investment Tips - Newser
Using economic indicators to assess MoonLake Immunotherapeutics potentialJuly 2025 Highlights & Real-Time Market Sentiment Alerts - Newser
How to use a screener to detect MoonLake Immunotherapeutics breakoutsWatch List & Trade Opportunity Analysis - Newser
How to track smart money flows in MoonLake ImmunotherapeuticsPortfolio Gains Report & Verified High Yield Trade Plans - Newser
What institutional flow reveals about MoonLake ImmunotherapeuticsInflation Watch & Weekly Momentum Stock Picks - Newser
What MACD and RSI say about MoonLake ImmunotherapeuticsWeekly Stock Summary & Safe Entry Zone Identification - Newser
Can technical indicators confirm MoonLake Immunotherapeutics’s reversalJuly 2025 News Drivers & Consistent Growth Stock Picks - Newser
Paradigm Biocapital Advisors LP Decreases Position in MoonLake Immunotherapeutics $MLTX - MarketBeat
What are MoonLake Immunotherapeutics’s growth leversWeekly Stock Recap & Safe Entry Zone Identification - خودرو بانک
Can MoonLake Immunotherapeutics keep up with sector leaders2025 Market Outlook & Community Shared Stock Ideas - خودرو بانک
Ranking MoonLake Immunotherapeutics among high performing stocks via toolsMarket Movers & Fast Entry Momentum Trade Alerts - Newser
MoonLake Immunotherapeutics stock prediction for this week2025 Top Gainers & Fast Moving Stock Trade Plans - Newser
Can a trend reversal in MoonLake Immunotherapeutics lead to recoveryPortfolio Risk Summary & Expert Verified Stock Movement Alerts - Newser
Will MoonLake Immunotherapeutics announce a stock splitWeekly Trend Recap & Weekly High Potential Stock Alerts - خودرو بانک
Can MoonLake Immunotherapeutics rally from current levels2025 Market Sentiment & Stepwise Entry/Exit Trade Alerts - Newser
When is the best time to exit MoonLake ImmunotherapeuticsStop Loss & Daily Stock Momentum Reports - Newser
MoonLake Immunotherapeutics stock daily chart insightsIndex Update & Technical Pattern Based Buy Signals - Newser
How hedge fund analytics apply to MoonLake Immunotherapeutics stockJuly 2025 Technicals & Real-Time Volume Triggers - Newser
Will MoonLake Immunotherapeutics price bounce be sustainable2025 Trade Ideas & Real-Time Stock Price Movement Reports - Newser
Using data models to predict MoonLake Immunotherapeutics stock movementWeekly Market Outlook & Smart Investment Allocation Tips - Newser
What Technical Tools Say About MoonLake Immunotherapeutics RecoveryQuarterly Profit Review & Precise Buy Zone Identification - beatles.ru
MoonLake Immunotherapeutics stock trend outlook and recovery pathWeekly Risk Summary & Free Real-Time Market Sentiment Alerts - Newser
What recovery options are there for MoonLake ImmunotherapeuticsTreasury Yields & Fast Entry High Yield Stock Tips - Newser
What Fibonacci levels say about MoonLake Immunotherapeutics reboundTrade Exit Report & Growth Focused Entry Reports - Newser
Visual analytics tools that track MoonLake Immunotherapeutics performanceWeekly Stock Analysis & Community Verified Trade Signals - Newser
Sentiment analysis tools applied to MoonLake ImmunotherapeuticsJuly 2025 EndofMonth & Trade Opportunity Analysis Reports - Newser
How sensitive is MoonLake Immunotherapeutics to inflation2025 Price Action Summary & Growth Focused Entry Reports - خودرو بانک
Moonlake Immunotherapeutics (MLTX) 財務データ
収益
当期純利益
現金流量
EPS
Moonlake Immunotherapeutics (MLTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Moukheibir Catherine | Director |
Jul 03 '25 |
Sale |
48.79 |
23,500 |
1,146,565 |
0 |
0.93%
0.10%
大文字化:
|
ボリューム (24 時間):